Editors’ Picks, March 2026: Pediatric Leukemia Development, Low-dose Tamoxifen Use, and More
In March, AACR's journals editors highlighted studies on the development of pediatric leukemia, the use of low-dose tamoxifen, and...
In March, AACR's journals editors highlighted studies on the development of pediatric leukemia, the use of low-dose tamoxifen, and...
In February, the editors of AACR's journals highlighted studies on the FDA’s accelerated approval pathway, how metabolism impacts prostate...
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
Colorectal cancer cases are becoming more common in younger adults, but there are now more options for screening beyond...
Researchers and a patient advocate weighed in on current and emerging treatment options for each stage of triple-negative breast...
Researchers are working on multiple innovative approaches to cancer vaccines, including nanoparticle delivery, a universal booster, and more.
What does a naked mole rat, a nuclear exporter that “moonlights” as a chromatin regulator, and the combined power...
What are fusion proteins? Learn more about how improperly combined genes and their protein products can lead to cancer.
At an AACR special conference on early-onset cancers, researchers discussed microplastics, the global rise of these cancers, and more.